FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571373669> ?p ?o ?g. }

• W2571373669 abstract "Abstract In childhood acute lymphoblastic leukaemia (ALL) overall event free survival exceeds 75% for most patients. Assessment of early responses to induction therapy by measurement of minimal residual disease (MRD) either by PCR or flow cytometry is a powerful independent prognostic factor. However, there is little data on whether the initial rate of bone marrow (BM) disease clearance is a contributory factor and if this varies for the cytogenetic subgroups, t(12;21) or hyperdiploid. Using 4-colour flow cytometry we examined the phenotypic characteristics at presentation of 29 cases (14 male and 15 female; age range 18–197 months; median 36 months) of B-lineage ALL. BM leukaemic cells were identified on the basis of light scatter characteristics, CD19 and CD45 expression. Geometric mean fluorescent intensities (MFI) were then assessed for a standard series of B, T and myeloid antigens. Novel phenotypic correlates were found (table 1) that allowed early prediction of the presence of t(12;21) or hyperdipoidy prior to confirmation by PCR, cytogenetics or FISH. Antigen t(12;21) (n=7) mean MFI (range) Hyperdiploid (n=15) mean MFI (range) P value (Mann-Whitney U) CD10 3636 (1597-5562) 1516 (777-3788) 0.001 CD20 9.0 (2.9-19.3) 75.9 (5.2-493.7) 0.062 CD66c 6.0 (3.5-8.1) 97.5 (10.1-310.8) <0.001 Using the unique phenotypic features of each subgroup, 4-colour combinations of antibodies were designed that would allow MRD monitoring of BM samples taken on days 8, 15 (optional) and day 28 (end) of induction therapy. These combinations would also be applied to BM samples throughout maintenance therapy. The t(12;21) cases showed rapid disease clearance with 2/7 patients becoming MRD negative by day 8 of induction and only one case MRD positive at day 28. In contrast, hyperdiploid cases showed a significantly slower initial clearance of leukaemic cells (P= 0.013 Mann Whitney U), with all cases MRD positive at day 8 and 4/15 MRD positive at day 28. Interestingly, MRD negativity at day 8 appeared to be a specific feature of t(12;21) disease, as in addition to the hyperdiploid cases, 7 other patients with non t(12;21) cytogenetic abnormalities were also MRD positive at day 8. Phenotypic shifts of residual leukaemic cells as measured by changes in MFI, were demonstrated throughout therapy by the hyperdiploid cases. They showed significant decreases in expression of CD34 and CD66c, whilst CD20 expression increased (All P<0.05). This phenomenon was not seen in the t(12;21) subgroup which retained a stable phenotype, though CD10 expression did fall, but not significantly (P = 0.07). As phenotypic changes are a consistent feature of hyperdiploid cases, they may indicate a preferential eradication of leukaemic subclones. Our findings have significant implications for flow cytometry based MRD studies of specific subtypes of B-ALL. The results raise doubts about the reliability of some antigens that are aberrantly expressed at presentation and therefore good candidates for MRD markers, as their expression changes significantly during therapy. Prospective monitoring of this cohort of patients is ongoing in order to assess the relationship between disease clearance and outcome at end of therapy." @default.
• W2571373669 created "2017-01-13" @default.
• W2571373669 creator A5004618702 @default.
• W2571373669 creator A5007146957 @default.
• W2571373669 creator A5011285650 @default.
• W2571373669 creator A5016068638 @default.
• W2571373669 creator A5021334976 @default.
• W2571373669 creator A5023773042 @default.
• W2571373669 creator A5083456305 @default.
• W2571373669 creator A5088805430 @default.
• W2571373669 date "2004-11-16" @default.
• W2571373669 modified "2023-10-16" @default.
• W2571373669 title "Differential Clearance Kinetics and Phenotypic Alterations of Leukaemic Blast Cells during Induction Therapy for Hyperdiploid and t(12;21) Childhood ALL: Implications for Minimal Residual Disease Detection by Flow Cytometry and Clinical Outcome." @default.
• W2571373669 doi "https://doi.org/10.1182/blood.v104.11.991.991" @default.
• W2571373669 hasPublicationYear "2004" @default.
• W2571373669 type Work @default.
• W2571373669 sameAs 2571373669 @default.
• W2571373669 citedByCount "0" @default.
• W2571373669 crossrefType "journal-article" @default.
• W2571373669 hasAuthorship W2571373669A5004618702 @default.
• W2571373669 hasAuthorship W2571373669A5007146957 @default.
• W2571373669 hasAuthorship W2571373669A5011285650 @default.
• W2571373669 hasAuthorship W2571373669A5016068638 @default.
• W2571373669 hasAuthorship W2571373669A5021334976 @default.
• W2571373669 hasAuthorship W2571373669A5023773042 @default.
• W2571373669 hasAuthorship W2571373669A5083456305 @default.
• W2571373669 hasAuthorship W2571373669A5088805430 @default.
• W2571373669 hasConcept C126322002 @default.
• W2571373669 hasConcept C142724271 @default.
• W2571373669 hasConcept C147483822 @default.
• W2571373669 hasConcept C196166836 @default.
• W2571373669 hasConcept C203014093 @default.
• W2571373669 hasConcept C2779823535 @default.
• W2571373669 hasConcept C2780007613 @default.
• W2571373669 hasConcept C553184892 @default.
• W2571373669 hasConcept C71924100 @default.
• W2571373669 hasConcept C86803240 @default.
• W2571373669 hasConcept C90924648 @default.
• W2571373669 hasConceptScore W2571373669C126322002 @default.
• W2571373669 hasConceptScore W2571373669C142724271 @default.
• W2571373669 hasConceptScore W2571373669C147483822 @default.
• W2571373669 hasConceptScore W2571373669C196166836 @default.
• W2571373669 hasConceptScore W2571373669C203014093 @default.
• W2571373669 hasConceptScore W2571373669C2779823535 @default.
• W2571373669 hasConceptScore W2571373669C2780007613 @default.
• W2571373669 hasConceptScore W2571373669C553184892 @default.
• W2571373669 hasConceptScore W2571373669C71924100 @default.
• W2571373669 hasConceptScore W2571373669C86803240 @default.
• W2571373669 hasConceptScore W2571373669C90924648 @default.
• W2571373669 hasLocation W25713736691 @default.
• W2571373669 hasOpenAccess W2571373669 @default.
• W2571373669 hasPrimaryLocation W25713736691 @default.
• W2571373669 hasRelatedWork W1893853672 @default.
• W2571373669 hasRelatedWork W2020417052 @default.
• W2571373669 hasRelatedWork W2076035400 @default.
• W2571373669 hasRelatedWork W2393340806 @default.
• W2571373669 hasRelatedWork W2399001313 @default.
• W2571373669 hasRelatedWork W2415112980 @default.
• W2571373669 hasRelatedWork W2557475059 @default.
• W2571373669 hasRelatedWork W25988901 @default.
• W2571373669 hasRelatedWork W3030951506 @default.
• W2571373669 hasRelatedWork W2549792497 @default.
• W2571373669 isParatext "false" @default.
• W2571373669 isRetracted "false" @default.
• W2571373669 magId "2571373669" @default.
• W2571373669 workType "article" @default.